O. Alpdogan

发表

DNA Immunization against Tissue-Restricted Antigens Enhances Tumor Immunity after Allogeneic Hemopoietic Stem Cell Transplantation1

J. Wolchok, M. Perales, M. V. D. van den Brink, 2006, The Journal of Immunology.

TransplantationAllogeneic Hemopoietic Stem Cell Antigens Enhances Tumor Immunity after DNA Immunization against Tissue-Restricted

J. Wolchok, M. Perales, A. Houghton, 2006 .

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.

M. V. D. van den Brink, B. Kappel, J. Ferrara, 2001, Blood.

Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation.

M. V. D. van den Brink, J. Crawford, A. Greenberg, 2003, Blood.

Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine.

M. V. D. van den Brink, G. Heller, E. Waldman, 2006, Blood.

IL-15: targeting CD8+ T cells for immunotherapy.

M. Perales, A. Diab, A. Cohen, 2005, Cytotherapy.

Molecular Imaging Reveals Skeletal Engraftment Sites of Transplanted Bone Marrow Cells

L. Bidaut, R. Blasberg, M. V. D. van den Brink, 2006, Cell transplantation.

Increasing T-cell age reduces effector activity but preserves proliferative capacity in a murine allogeneic major histocompatibility complex-mismatched bone marrow transplant model.

M. V. D. van den Brink, T. Kupper, S. Burakoff, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CCR2 is required for CD8-induced graft-versus-host disease.

M. V. D. van den Brink, G. Heller, G. Murphy, 2005, Blood.

CC chemokine receptor 2 is required for CD 8-induced graft-versus-host disease

Sydney, G. Heller, G. Murphy, 2005 .

Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders.

T. Ergun, H. Direskeneli, Ş. Yavuz, 1998, British journal of rheumatology.

Kaposi sarcoma mimicking multiple cherry angiomata clinically and histologically in a patient with Sezary syndrome: an unusual presentation.

B. Pro, O. Alpdogan, Joya Sahu, 2015, Clinical lymphoma, myeloma & leukemia.

Organ-derived dendritic cells have differential effects on alloreactive T cells.

Christopher G. King, M. V. D. van den Brink, G. Heller, 2008, Blood.

Special Considerations in the Treatment of Mycosis Fungoides

P. Porcu, W. Shi, O. Alpdogan, 2019, American Journal of Clinical Dermatology.

Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization

U. Martinez-outschoorn, N. Flomenberg, M. Kasner, 2017, Bone Marrow Transplantation.

GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease

P. Pandolfi, M. V. D. van den Brink, A. Houghton, 2004, The Journal of experimental medicine.

DiseaseAmeliorates Experimental Graft-versus-Host Allogeneic Bone Marrow Transplantation Absence of P-Selectin in Recipients of

Christopher G. King, R. Jenq, A. M. Holland, 2010 .

Absence of P-Selectin in Recipients of Allogeneic Bone Marrow Transplantation Ameliorates Experimental Graft-versus-Host Disease

Christopher G. King, R. Jenq, M. V. D. van den Brink, 2010, The Journal of Immunology.

LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease

A. Greenberg, G. Heller, G. Murphy, 2004 .

Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation

Christopher G. King, R. Jenq, M. V. D. van den Brink, 2011, PloS one.

Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice.

M. V. D. van den Brink, D. Wong, M. Moore, 2004, Experimental hematology.

IL-7 and IL-15: therapeutic cytokines for immunodeficiency.

M. V. D. van den Brink, O. Alpdogan, 2005, Trends in immunology.

Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity.

Christopher G. King, M. V. D. van den Brink, A. Chow, 2007, Blood.

LPAM ( (cid:1) 4 (cid:2) 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease

A. Greenberg, G. Heller, G. Murphy, 2004 .

Regeneration Keratinocyte Growth Factor (KGF) Is Required For Post-Natal Thymic

M. V. D. van den Brink, D. Gray, R. Boyd, 2011 .

New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity

H. Wong, N. Flomenberg, Emily K. Jeng, 2017, Oncotarget.

Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinoma

N. Flomenberg, O. Alpdogan, T. Budak‐Alpdogan, 2013, Bone Marrow Transplantation.

The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.

P. Porcu, A. Gru, O. Alpdogan, 2019, Chinese clinical oncology.

IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

M. V. D. van den Brink, A. Greenberg, B. Kappel, 2003, The Journal of clinical investigation.

Rhamm Expression and Isoform Balance Predicts Aggressive Disease and Poor Survival in Multiple Myeloma

M. V. D. van den Brink, D. Kofler, M. Schlee, 2022 .

7-4-2017 New interleukin-15 superagonist ( IL-15 SA ) significantly enhances graft-versus-tumor activity

H. Wong, N. Flomenberg, Emily K. Jeng, 2018 .

Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT

N. Flomenberg, A. Durham, O. Alpdogan, 2013, Bone Marrow Transplantation.

Absence of the (cid:1) 7 Integrin Results in Less Graft-Versus-Host Disease Due to Decreased Homing of Alloreactive T Cells to Intestine

G. Heller, E. Waldman, Sydney X Lu, 2005 .

The effect of 1,25 dihydroxyvitamin D3 on lymphocyte transformation in patients with chronic renal failure.

R. Lawrence, O. Alpdogan, E. Akoğlu, 1995, Internal medicine.

Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma.

L. Wilson, K. Roberts, M. Girardi, 2015, Journal of the American Academy of Dermatology.

Double G0/G1 peak in the DNA histogram of aberrant marker positive acute leukemia patients is associated with a poor clinical outcome.

M. Bayık, E. Ekşioğlu-Demiralp, O. Alpdogan, 1999, Leukemia & lymphoma.

Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL)

P. Porcu, J. Gong, O. Alpdogan, 2019, Front. Oncol..

Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.

M. Bayık, M. Aktan, E. Ekşioğlu-Demiralp, 1996, Leukemia.

Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.

M. Perales, M. V. D. van den Brink, J. Halm, 2001, Blood.

A Prospective, Randomized Trial Examining the Use of G-CSF versus No G-CSF in Patients Post-Autologous Transplant.

P. Porcu, N. Flomenberg, M. Kasner, 2022, Transplantation and cellular therapy.

Rıchter's Syndrome ın patıents wıth chronıc lymphocytıc leukemıa

S. Küllü, M. Bayık, A. Toprak, 1999 .

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

R. Advani, J. Briones, G. Salles, 2019, The Lancet.

LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.

M. V. D. van den Brink, A. Greenberg, G. Heller, 2004, Blood.

Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.

D. Banerjee, J. Bertino, M. Moore, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation.

B. Leiby, U. Martinez-outschoorn, W. Kraft, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion gene

F. Maley, D. Banerjee, J. Bertino, 2004, Cancer Gene Therapy.

Keratinocyte growth factor (KGF) is required for post-natal thymic regeneration

R. Boyd, V. Hubbard, Adam A. Kochman, 2005 .

IFN-γ and Fas Ligand Are Required for Graft-versus-Tumor Activity against Renal Cell Carcinoma in the Absence of Lethal Graft-versus-Host Disease1

M. V. D. van den Brink, G. Heller, G. Murphy, 2007, The Journal of Immunology.

Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.

Christopher G. King, J. Wolchok, M. Perales, 2009, Blood.

A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease.

U. Martinez-outschoorn, I. Chervoneva, W. Shi, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double haploidentical hematopoietic stem cell transplantation results in successful engraftment of bone marrow from both donors without graft-versus-host or graft-versus-graft effects.

N. Flomenberg, O. Alpdogan, C. Sauter, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation.

M. V. D. van den Brink, G. Heller, G. Murphy, 2005, Blood.

Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells

R. Lavker, O. Alpdogan, J. Wolosin, 2005, Journal of Cell Science.

Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma

J. Wagner, U. Martinez-outschoorn, C. Daskalakis, 2015 .

Immune tolerance and transplantation.

M. V. D. van den Brink, O. Alpdogan, 2012, Seminars in oncology.

T cells require TRAIL for optimal graft-versus-tumor activity

J. Crawford, A. Greenberg, J. Peschon, 2002, Nature Medicine.

Enhanced Immune Reconstitution by Sex Steroid Ablation following Allogeneic Hemopoietic Stem Cell Transplantation1

M. V. D. van den Brink, A. Greenberg, J. Sutherland, 2007, The Journal of Immunology.

Primary central nervous system plasmablastic lymphoma in an HIV-positive patient

R. Rhoades, J. Gong, O. Alpdogan, 2019, BMJ Case Reports.

Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).

P. Porcu, A. Mishra, A. Gru, 2018, Cancer treatment and research.

Allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and Sézary syndrome: a concise review.

P. Porcu, O. Alpdogan, N. Nikbakht, 2019, Chinese clinical oncology.

Amlodipine-induced hypersensitivity reaction mimicking CD30+ mycosis fungoides

W. Shi, O. Alpdogan, Joya Sahu, 2016, JAAD case reports.

IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease.

M. V. D. van den Brink, G. Heller, G. Murphy, 2007, Journal of immunology.

Immune evasion and current immunotherapy strategies in mycosis fungoides (MF) and Sézary syndrome (SS).

P. Porcu, A. Mishra, O. Alpdogan, 2019, Chinese clinical oncology.

STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease.

Christopher G. King, R. Balderas, G. Altan-Bonnet, 2008, Blood.

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.

J. Vose, S. Montoto, Sonali M. Smith, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Two-Step Allogeneic Stem Cell Transplant Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies.

P. Porcu, U. Martinez-outschoorn, N. Flomenberg, 2021, Transplantation and cellular therapy.

Low Non-Relapse Mortality after HLA Matched Related Two-Step Hematopoietic Stem Cell Transplantation using Cyclophosphamide (CY) for Graft versus Host Disease Prophylaxis and the Potential Impact of Non-CY-Exposed T Cells on Outcomes.

P. Porcu, U. Martinez-outschoorn, N. Flomenberg, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A prospective cohort study of Condensed low dose total skin electron beam therapy for mycosis fungoides: reduction of disease burden and improvement in quality of life.

P. Porcu, W. Shi, O. Alpdogan, 2020, Journal of the American Academy of Dermatology.

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

K. Savage, P. Zinzani, S. Horwitz, 2022, Blood advances.

Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination

Inna Chervenova, P. Porcu, U. Martinez-outschoorn, 2022, Frontiers in Oncology.

Survival Disparities of Diffuse Large B-Cell Lymphoma in a Community-Based Inner-City Cancer Center.

Vinicius Jorge, Sorab Gupta, O. Alpdogan, 2020, Clinical lymphoma, myeloma & leukemia.

Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor

P. Porcu, O. Alpdogan, N. Nikbakht, 2022, Case Reports in Oncology.

Skindex-29 scores indicate poor quality of life in early stage mycosis fungoides.

P. Porcu, W. Shi, O. Alpdogan, 2020, Journal of dermatological science.